Resumen de Investigación

Hybrid telemedicine improves glycemic control in type 1 diabetes

Moderate confidence
Low bias
Última actualización 8 de julio de 2026

Conclusión Clave:

This study evaluated a hybrid telemedicine approach for adults with type 1 diabetes against standard clinical practice, finding a significant reduction in HbA1c levels.

Estudio de un Vistazo

Qué se estudió

Hybrid telemedicine approach with face-to-face follow-up in adults with type 1 diabetes.

Participantes

Young Adult (19–39), Middle Aged (40-64)

Male, Female

with T1 Diabetes

Intervención

Hybrid telemedicine approach

Resultados

Quality of life measured by ViDa1 Questionnaire, HbA1c, Glycemic variability, Time below target range, Adverse events

Financiamiento

No Patrocinado por la Industria

Guarda este estudio y agrega notas a tu biblioteca de investigación.

Efectos Principales

HbA1c levels decreased from 6.9% to 6.7% after 12 months (p=0.006).

No statistically significant differences in quality of life were found.

No increase in adverse events was reported despite fewer in-person visits.

Resumen de Evidencia

InterventionOutcomeMeasured ChangeStudy Effect
Devices & Technology
Hybrid closed-loop system
(Devices & Technology)
Safety
Adverse events incidence
(Safety)
No Change
Unclear
Devices & Technology
Hybrid closed-loop system
(Devices & Technology)
Glycemic Control
Glucose variability
(Glycemic Control)
No Change
Unclear
Devices & Technology
Hybrid closed-loop system
(Devices & Technology)
Glycemic Control
HbA1c
(Glycemic Control)
Decrease
Strong
Devices & Technology
Hybrid closed-loop system
(Devices & Technology)
Patient-Reported
Quality of life
(Patient-Reported)
No Change
Unclear
Devices & Technology
Hybrid closed-loop system
(Devices & Technology)
Glycemic Control
Time in range
(Glycemic Control)
No Change
Unclear

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

La Evidencia Sugiere

  • HbA1c levels decreased by 0.2% (p=0.006) with the hybrid approach.
  • Quality of life scores showed no significant differences between groups.
  • No increase in adverse events was noted despite reduced in-person visits.
who this applies

A quién se aplica

  • Adults with type 1 diabetes.
  • Individuals seeking alternatives to standard clinical practice.
keep in mind

Tener en Cuenta

  • The study did not measure all relevant outcomes, such as glycemic variability.
  • Findings may not be generalizable to all populations with diabetes.
  • The long-term effectiveness of the hybrid approach remains to be determined.
between the lines

Entre Líneas

  • No specific results reported for glycemic variability.
  • Limited information on time below target range.
  • Effectiveness of the hybrid approach remains unclear for some outcomes.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Referencia de la Revista

Lía N, Esther DLC, Edurne L, et al. A hybrid telemedicine approach for adults with type 1 diabetes using an advanced closed-loop system: a randomized clinical trial. Therapeutic Advances in Endocrinology and Metabolism. 2024;15:20420188241288789. doi:10.1177/20420188241288789

View DOIView on PubMedView on PMC

Connected Evidence

Discover how this study fits into the broader diabetes evidence landscape.

This study contributes to evidence on Insulin Delivery Systems and Glucose Variability, Insulin Delivery Systems and CGM Time in Range.

Relaciones de evidencia relacionadas

Explore in Evidence Archive

This study contributes to the evidence on the following intervention–outcome relationships.

Preguntas que esta evidencia ayuda a responder

Key clinical and research questions this study contributes to.

Does hybrid closed-loop system improve Glucose variability?

Based on connected evidence for Hybrid closed-loop system and Glucose variability.

Does hybrid closed-loop system affect Time in range in people with diabetes?

Exploring evidence on Hybrid closed-loop system and Time in range outcomes.

Cómo se generan las conexiones

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.